Michael Gelband’s Dillards DDS Stock Holding History

Michael Gelband’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50,000	Closed	-$3.11M	–	1393
2019 Q2	$3.11M	Buy	+50,000	New	+$3.21M	0.12%	113

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Michael Gelband's DDS Position: Q2 2026 in Review

Michael Gelband sold out of Dillards (DDS) in Q2 2026, closing a stake of 3,639 shares — an estimated $2.08M sold.

Michael Gelband first reported a position in DDS in Q3 2019 and held it in 20 quarters. The position peaked at $8.39M in Q3 2021. 309 funds tracked by Wall St. Rank hold DDS as of Q2 2026.

Michael Gelband reported no remaining Dillards position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 3,639 Dillards shares in Q2 2026, an estimated $2.08M.
Michael Gelband first reported a position in Dillards in Q3 2019 and held it in 20 quarters.
Michael Gelband's Dillards position peaked at $8.39M in Q3 2021.
309 funds tracked by Wall St. Rank held Dillards as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.